PSU Profiles
Keywords
Last Name
Institution

Jonathan Foulds

TitleProfessor
InstitutionCollege of Medicine
DepartmentPublic Health Sciences
Address500 University Drive Hershey PA 17033
Mailbox: CH69
Phone7175313504
Email

 Overview 
 overview
PREFERRED TITLE/ROLE: Professor of Public Health Sciences and Psychiatry

INSTITUTE(S)/ CENTER(S):
Penn State Tobacco Center of Regulatory Science
Cancer Institute

EDUCATION:
Ph.D., Psychology, University of London (1997)
M.App.Sci., Clinical Psychology, University of Glasgow (1989)
M.A., Psychology, University of Aberdeen (1987)

NARRATIVE:
Jonathan Foulds, PhD. is a Professor of Public Health Sciences and Psychiatry at Penn State University, College of Medicine. After obtaining a first class honors degree in psychology at University of Aberdeen in Scotland, he trained as a clinical psychologist at the University of Glasgow, and then spent most of his career developing and evaluating methods to help smokers beat their addiction to tobacco. He obtained his PhD at the Institute of Psychiatry, University of London and worked at St George’s Hospital Medical School as the UK’s first “lecturer in tobacco addiction”. He then moved to University of Surrey and continued to work as a principal clinical psychologist at Broodmoor Hospital, a large maximum security facility for mentally disordered offenders. He was on the Management Group of the Hungarian Anti-Smoking Campaign (1995-6), has been a technical leader of a World Health Organization project to improve the regulation of tobacco dependence treatment in Europe (2000), and was Director of Research for the UK charity, Quit, which ran the largest telephone helpline for smokers in the world at that time. From 2000-2010 he was the director of the Tobacco Dependence Program at the University of Medicine & Dentistry of New Jersey – School of Public Health. Although primarily funded for service and training activities, TDP program members published over 90 articles on tobacco during that period. He was a founding member and Vice President of the Association for the Treatment of Tobacco Use and Dependence (ATTUD) 2004-6. In the USA he has been a principal investigator on grants totaling well over $27 million, and has been invited to speak on smoking cessation in over 15 countries. Dr. Foulds acts as a Health Expert on the www.WebMD.com Smoking Cessation Community. He has published over 80 papers on tobacco in peer-reviewed scientific journals and continues to treat addicted smokers, teach on smoking cessation and conduct research on tobacco and health at Penn State College of Medicine in Hershey, PA.

Pdf copies of many of these published papers can be found via the following link: http://www.tobaccoprogram.org/staffarticles.htm

Summaries of most of his publications can be found at: PubMed or Google Scholar


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D. Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach. Eur Addict Res. 2014 Apr 3; 20(5):218-225.
    View in: PubMed
  2. Veldheer S, Yingst J, Foulds G, Hrabovsky S, Berg A, Sciamanna C, Foulds J. Once bitten, twice shy: concern about gaining weight after smoking cessation and its association with seeking treatment. Int J Clin Pract. 2014 Mar; 68(3):388-95.
    View in: PubMed
  3. Hajek P, Foulds J, Houezec JL, Sweanor D, Yach D. Should e-cigarettes be regulated as a medicinal device? Lancet Respir Med. 2013 Aug; 1(6):429-31.
    View in: PubMed
  4. Foulds J, Russ C, Yu CR, Zou KH, Galaznik A, Franzon M, Berg A, Hughes JR. Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials. Nicotine Tob Res. 2013 Nov; 15(11):1849-57.
    View in: PubMed
  5. Hughes JR, Cummings KM, Foulds J, Shiffman S, West R. Effectiveness of nicotine replacement therapy--a rebuttal. Addiction. 2012 Aug; 107(8):1527-8.
    View in: PubMed
  6. Steinberg ML, Williams JM, Gandhi KK, Foulds J, Epstein EE, Brandon TH. Task persistence predicts smoking cessation in smokers with and without schizophrenia. Psychol Addict Behav. 2012 Dec; 26(4):850-8.
    View in: PubMed
  7. Foulds J, Veldheer S, Berg A. Electronic cigarettes: a response to Leelavathi and Das. Int J Clin Pract. 2012 Apr; 66(4):417-8.
    View in: PubMed
  8. Fagerström K, Russ C, Yu CR, Yunis C, Foulds J. The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob Res. 2012 Dec; 14(12):1467-73.
    View in: PubMed
  9. Foulds J, Veldheer S. Commentary on Etter & Bullen (2011): could E-cigs become the ultimate nicotine maintenance device? Addiction. 2011 Nov; 106(11):2029-30.
    View in: PubMed
  10. Williams JM, Zimmermann MH, Steinberg ML, Gandhi KK, Delnevo C, Steinberg MB, Foulds J. A comprehensive model for mental health tobacco recovery in new jersey. Adm Policy Ment Health. 2011 Sep; 38(5):368-83.
    View in: PubMed
  11. Oredein T, Foulds J. Causes of the decline in cigarette smoking among African American youths from the 1970s to the 1990s. Am J Public Health. 2011 Oct; 101(10):e4-e14.
    View in: PubMed
  12. Foulds J, Veldheer S, Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract. 2011 Oct; 65(10):1037-42.
    View in: PubMed
  13. Williams JM, Steinberg MB, Steinberg ML, Gandhi KK, Ulpe R, Foulds J. Varenicline for tobacco dependence: panacea or plight? Expert Opin Pharmacother. 2011 Aug; 12(11):1799-812.
    View in: PubMed
  14. Foulds J, Hooper MW, Pletcher MJ, Okuyemi KS. Do smokers of menthol cigarettes find it harder to quit smoking? Nicotine Tob Res. 2010 Dec; 12 Suppl 2:S102-9.
    View in: PubMed
  15. Steinberg ML, Williams JM, Gandhi KK, Foulds J, Brandon TH. Lower task persistence in smokers with schizophrenia as compared to non-psychiatric control smokers. Psychol Addict Behav. 2010 Dec; 24(4):724-9.
    View in: PubMed
  16. Borland R, Fagerström K, Foulds J, McNeill A, Ramström L. FCTC background report on smokeless tobacco is incompatible with WHO scientific reports. Addiction. 2011 Jan; 106(1):225-7.
    View in: PubMed
  17. Steinberg MB, Bover MT, Richardson DL, Schmelzer AC, Williams JM, Foulds J. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. Drug Alcohol Depend. 2011 Mar 1; 114(1):77-81.
    View in: PubMed
  18. Williams JM, Gandhi KK, Lu SE, Kumar S, Shen J, Foulds J, Kipen H, Benowitz NL. Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine Tob Res. 2010 Aug; 12(8):855-9.
    View in: PubMed
  19. Foulds J, Parth JD, Bover-Manderski MT. Blood glucose levels produced by glucose tablets in abstaining smokers. Psychopharmacology (Berl). 2010 Apr; 209(3):283-4.
    View in: PubMed
  20. Foulds J. Use of nicotine replacement therapy to treat nicotine withdrawal syndrome and aid temporary abstinence. Int J Clin Pract. 2010 Feb; 64(3):292-4.
    View in: PubMed
  21. Foulds J, Schmelzer AC, Steinberg MB. Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease. Int J Clin Pract. 2010 Jan; 64(2):142-6.
    View in: PubMed
  22. Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL. Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. Ann Intern Med. 2009 Apr 7; 150(7):447-54.
    View in: PubMed
  23. Gandhi KK, Foulds J, Steinberg MB, Lu SE, Williams JM. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract. 2009 Mar; 63(3):360-7.
    View in: PubMed
  24. Williams JM, Gandhi KK, Karavidas MK, Steinberg ML, Lu SE, Foulds J. Open-Label Study of Craving in Smokers With Schizophrenia Using Nicotine Nasal Spray Compared to Nicotine Patch. J Dual Diagn. 2008 Oct 1; 4(4):355-376.
    View in: PubMed
  25. Foulds J. [Commentary] improving NRT labeling and correcting public misperceptions. Addiction. 2008 Aug; 103(8):1379-80.
    View in: PubMed
  26. Steinberg MB, Schmelzer AC, Richardson DL, Foulds J. The case for treating tobacco dependence as a chronic disease. Ann Intern Med. 2008 Apr 1; 148(7):554-6.
    View in: PubMed
  27. Foulds J, Furberg H. Is low-nicotine Marlboro snus really snus? Harm Reduct J. 2008; 5:9.
    View in: PubMed
  28. Bover MT, Foulds J, Steinberg MB, Richardson D, Marcella SW. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome. Int J Clin Pract. 2008 Feb; 62(2):182-90.
    View in: PubMed
  29. Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007 Aug; 9(8):873-81.
    View in: PubMed
  30. Foulds J, Kozlowski L. Snus--what should the public-health response be? Lancet. 2007 Jun 16; 369(9578):1976-8.
    View in: PubMed
  31. Kozlowski LT, Giovino GA, Edwards B, Difranza J, Foulds J, Hurt R, Niaura R, Sachs DP, Selby P, Dollar KM, Bowen D, Cummings KM, Counts M, Fox B, Sweanor D, Ahern F. Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking. Addict Behav. 2007 Oct; 32(10):2140-50.
    View in: PubMed
  32. Delnevo C, Lewis MJ, Foulds J. Taxing moist snuff by weight ain't worth spit. Tob Control. 2007 Feb; 16(1):69.
    View in: PubMed
  33. Williams JM, Foulds J. Successful tobacco dependence treatment in schizophrenia. Am J Psychiatry. 2007 Feb; 164(2):222-7; quiz 373.
    View in: PubMed
  34. Steinberg MB, Foulds J. Rimonabant for treating tobacco dependence. Vasc Health Risk Manag. 2007; 3(3):307-11.
    View in: PubMed
  35. Han ES, Foulds J, Steinberg MB, Gandhi KK, West B, Richardson DL, Zelenetz S, Dasika J. Characteristics and smoking cessation outcomes of patients returning for repeat tobacco dependence treatment. Int J Clin Pract. 2006 Sep; 60(9):1068-74.
    View in: PubMed
  36. Foulds J, Gandhi KK, Steinberg MB, Richardson DL, Williams JM, Burke MV, Rhoads GG. Factors associated with quitting smoking at a tobacco dependence treatment clinic. Am J Health Behav. 2006 Jul-Aug; 30(4):400-12.
    View in: PubMed
  37. Ziedonis D, Haberstroh S, Hanos Zimmermann M, Miceli M, Foulds J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolesc Med Clin. 2006 Jun; 17(2):381-410.
    View in: PubMed
  38. Ramström LM, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control. 2006 Jun; 15(3):210-4.
    View in: PubMed
  39. Foulds J, Williams JM, Gandhi KK. Racial differences in lung cancer. N Engl J Med. 2006 May 4; 354(18):1951-3; author reply 1951-3.
    View in: PubMed
  40. Foulds J. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. Int J Clin Pract. 2006 May; 60(5):571-6.
    View in: PubMed
  41. Foulds J, Ramstrom L. Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II? Cancer Causes Control. 2006 Mar; 17(2):227-8.
    View in: PubMed
  42. Ziedonis DM Williams JM, Steinberg ML, Foulds J. Primary Psychiatry. Addressing tobacco addiction in office-based management of psychiatric disorders: practical considerations. 2006; 13:51-63.
  43. Delnevo CN, Foulds J, Vorbach U, Kazimir E. Seasonal variations in stage of change among Quitline clients. Tob Control. 2006 Feb; 15(1):70-1.
    View in: PubMed
  44. Foulds J, Steinberg MB, Williams JM, Ziedonis DM. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev. 2006 Jan; 25(1):59-71.
    View in: PubMed
  45. Foulds J, Williams J, Order-Connors B, Edwards N, Dwyer M, Kline A, Ziedonis DM. Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment: New Jersey's experience. Alcohol Res Health. 2006; 29(3):236-40.
    View in: PubMed
  46. Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006; 29(3):228-35.
    View in: PubMed
  47. Steinberg MB, Foulds J, Richardson DL, Burke MV, Shah P. Pharmacotherapy and smoking cessation at a tobacco dependence clinic. Prev Med. 2006 Feb; 42(2):114-9.
    View in: PubMed
  48. Delnevo CD, Foulds J, Hrywna M. Trading tobacco: are youths choosing cigars over cigarettes? Am J Public Health. 2005 Dec; 95(12):2123.
    View in: PubMed
  49. Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res. 2005 Nov 15; 79(2-3):323-35.
    View in: PubMed
  50. Williams JM, Foulds J, Dwyer M, Order-Connors B, Springer M, Gadde P, Ziedonis DM. The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey. J Subst Abuse Treat. 2005 Jun; 28(4):331-40.
    View in: PubMed
  51. Foulds J, Williams J. Tobacco use and cataracts in patients with schizophrenia. Am J Psychiatry. 2005 May; 162(5):1028; author reply 1029.
    View in: PubMed
  52. Delnevo CD, Hrywna M, Foulds J, Steinberg MB. Cigar use before and after a cigarette excise tax increase in New Jersey. Addict Behav. 2004 Dec; 29(9):1799-807.
    View in: PubMed
  53. Steinberg MB, Delnevo CD, Foulds J, Pevzner E. Characteristics of smoking and cessation behaviors among high school students in New Jersey. J Adolesc Health. 2004 Sep; 35(3):231-3.
    View in: PubMed
  54. Williams JM, Ziedonis DM, Foulds J. A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatr Serv. 2004 Sep; 55(9):1064-6.
    View in: PubMed
  55. Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis DM. Advances in pharmacotherapy for tobacco dependence. Expert Opin Emerg Drugs. 2004 May; 9(1):39-53.
    View in: PubMed
  56. Foulds J, Ramstrom L, Burke M, Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control. 2003 Dec; 12(4):349-59.
    View in: PubMed
  57. May S, West R, Hajek P, Nilsson F, Foulds J, Meadow A. The use of videos to inform smokers about different nicotine replacement products. Patient Educ Couns. 2003 Oct; 51(2):143-7.
    View in: PubMed
  58. Krejci J, Foulds J. Psychiatric Annals. Engaging patients in tobacco dependence treatment: assessment and motivational techniques. 2003; 33:436-444.
  59. Harakas P, Foulds J. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers. Psychopharmacology (Berl). 2002 May; 161(3):271-7.
    View in: PubMed
  60. Foulds J. Effectiveness of smoking cessation initiatives. Smoking cessation services show good return on investment. BMJ. 2002 Mar 9; 324(7337):608-9.
    View in: PubMed
  61. Foulds J, Burke M, Richardson D, Kazimir E. Tobacco dependence treatment services in New Jersey. N J Med. 2002 Mar; 99(3):23-8.
    View in: PubMed
  62. McNeill A, Foulds J, Bates C. Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction. 2001 Dec; 96(12):1757-68.
    View in: PubMed
  63. Herbert M, Foulds J, Fife-Schaw C. No effect of cigarette smoking on attention or mood in non-deprived smokers. Addiction. 2001 Sep; 96(9):1349-56.
    View in: PubMed
  64. Hajek P, West R, Lee A, Foulds J, Owen L, Eiser JR, Main N. Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction. 2001 Mar; 96(3):485-94.
    View in: PubMed
  65. West R, Hajek P, Nilsson F, Foulds J, May S, Meadows A. Individual differences in preferences for and responses to four nicotine replacement products. Psychopharmacology (Berl). 2001 Jan 1; 153(2):225-30.
    View in: PubMed
  66. West R, Hajek P, Foulds J, Nilsson F, May S, Meadows A. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology (Berl). 2000 Apr; 149(3):198-202.
    View in: PubMed
  67. Foulds J. The new NHS smoking campaign BMJ. 2000 Feb 12; 320(7232):454.
    View in: PubMed
  68. Foulds J. The psychology of tobacco addiction: why it is difficult to stop smoking. Monaldi Arch Chest Dis. 1999 Dec; 54(6):495-7.
    View in: PubMed
  69. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med. 1999 Sep 27; 159(17):2033-8.
    View in: PubMed
  70. Foulds J. Killing for profit: where is the outrage? BMJ. 1999 Jul 24; 319(7204):266.
    View in: PubMed
  71. Foulds J, Russell MA, Jarvis MJ, Feyerabend C. Nicotine absorption and dependence in unlicensed lozenges available over the counter. Addiction. 1998 Sep; 93(9):1427-31.
    View in: PubMed
  72. Foulds J, Stapleton JA, Bell N, Swettenham J, Jarvis MJ, Russell MA. Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug Alcohol Depend. 1997 Mar 14; 44(2-3):105-15.
    View in: PubMed
  73. Foulds J. A role for dopamine in nicotine psychosis? Addiction. 1996 Sep; 91(9):1388-9.
    View in: PubMed
  74. Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell MA. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl). 1996 Sep; 127(1):31-8.
    View in: PubMed
  75. Foulds J. Strategies for smoking cessation. Br Med Bull. 1996 Jan; 52(1):157-73.
    View in: PubMed
  76. Foulds J, Godfrey C. Counting the costs of children's smoking. BMJ. 1995 Oct 28; 311(7013):1152-4.
    View in: PubMed
  77. Foulds J, Ghodse AH. The role of nicotine in tobacco smoking: implications for tobacco control policy. J R Soc Health. 1995 Aug; 115(4):225-30.
    View in: PubMed
  78. Foulds J, Toone B. A case of nicotine psychosis? Addiction. 1995 Mar; 90(3):435-7.
    View in: PubMed
  79. Foulds J, Stapleton J. Evidence that cotinine is psychoactive? Clin Pharmacol Ther. 1995 Jan; 57(1):95-7.
    View in: PubMed
  80. Foulds J, Ghodse H. . Advances in Psychiatric Treatment. Treatment of tobacco dependence. 1995; 1:116-123.
  81. Foulds J, Bryant A, Stapleton J, Jarvis MJ, Russell MA. The stability of cotinine in unfrozen saliva mailed to the laboratory. Am J Public Health. 1994 Jul; 84(7):1182-3.
    View in: PubMed
  82. Foulds J, McSorley K, Sneddon J, Feyerabend C, Jarvis MJ, Russell MA. Effect of subcutaneous nicotine injections of EEG alpha frequency in non-smokers: a placebo-controlled pilot study. Psychopharmacology (Berl). 1994 Jun; 115(1-2):163-6.
    View in: PubMed
  83. Foulds J. Addiction. Nicotine replacement does work: time to stop sitting on the fence. 1994; 89(4):438-439.
  84. Foulds J. Detrimental effects of nicotine on mood? Addiction. 1994 Feb; 89(2):136-8; discussion 144-6.
    View in: PubMed
  85. Foulds J, Feyerabend C, Stapleton J, Jarvis MJ, Russell MAH. J Smoking-Related Disorders. Stability of nicotine and cotinine in unfrozen plasma. 1994; 5:41-44.
  86. Foulds J. Does nicotine replacement therapy work? Addiction. 1993 Nov; 88(11):1473-8.
    View in: PubMed
  87. Foulds J, Stapleton J, Hayward M, Russell MA, Feyerabend C, Fleming T, Costello J. Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial. Arch Fam Med. 1993 Apr; 2(4):417-23.
    View in: PubMed
  88. Foulds J. Behav Psychotherapy. Cerebral circulation during treatment of blood-injury phobia: a case study. 1993; 21:137-146.
  89. Jarvis MJ, Foulds J, Feyerabend C. Exposure to passive smoking among bar staff. Br J Addict. 1992 Jan; 87(1):111-3.
    View in: PubMed
  90. Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MA. Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berl). 1992; 106(3):421-7.
    View in: PubMed
  91. Foulds J, Wiedmann K, Patterson J, Brooks N. The effects of muscle tension on cerebral circulation in blood-phobic and non-phobic subjects. Behav Res Ther. 1990; 28(6):481-6.
    View in: PubMed
  92. Crawford JR, Stewart LE, Cochrane RH, Foulds JA, Besson JA, Parker DM. Estimating premorbid IQ from demographic variables: regression equations derived from a UK sample. Br J Clin Psychol. 1989 Sep; 28 ( Pt 3):275-8.
    View in: PubMed
  93. Foulds J, McAllister H, Foulds S. J Psychophysiol. The relationship between socialization and electrodermal activity in normal subjects. 1988; 2:227-230.
Foulds's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_